Capricor Therapeutics (CAPR) FCF Margin Growth (3y) (2014 - 2024)
Capricor Therapeutics (CAPR) FCF Margin Growth (3y) (2014 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15,064.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 723.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1,409.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Capricor Therapeutics | 457.86 Mn | 457.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 205,914.00 |
| Mar 31, 2024 | 822,869.00 |
| Dec 31, 2023 | 704,198.00 |
| Sep 30, 2023 | 1.84 Mn |
| Jun 30, 2023 | 401,600.00 |
| Mar 31, 2023 | 78,533.00 |
| Dec 31, 2022 | 1,237.00 |
| Sep 30, 2022 | 77,009.00 |
| Jun 30, 2021 | -145,621.00 |
| Mar 31, 2021 | -734,656.00 |
| Dec 31, 2020 | -658,192.00 |
| Sep 30, 2020 | -1.75 Mn |
| Jun 30, 2020 | -307,383.00 |
| Mar 31, 2020 | -12,479.00 |
| Dec 31, 2019 | -30,731.00 |
| Sep 30, 2019 | -90,496.00 |
| Jun 30, 2019 | 181,706.00 |
| Mar 31, 2019 | -34,959.00 |
| Dec 31, 2018 | -44,607.00 |
| Sep 30, 2018 | -59,370.00 |